BioCentury
ARTICLE | Company News

Charles River gains on takeout speculation

January 11, 2012 1:28 AM UTC

Charles River Laboratories International Inc. (NYSE:CRL) gained $4.79 (17%) to $32.47 on Tuesday after media reports that management is considering a sale of the company. Charles River declined to com...